Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

RIC3 variants are not associated with Parkinson’s Disease in large European, Latin American, or East Asian cohorts

View ORCID ProfileKajsa Brolin, Sara Bandres-Ciga, Hampton Leonard, View ORCID ProfileMary B. Makarious, Cornelis Blauwendraat, View ORCID ProfileIgnacio F Mata, Jia Nee Foo, Lasse Pihlstrøm, Maria Swanberg, Ziv Gan-Or, Manuela MX Tan, International Parkinson’s Disease Genomics Consortium (IPDGC)
doi: https://doi.org/10.1101/2021.06.22.21259012
Kajsa Brolin
1Lund University, Translational Neurogenetics Unit, Wallenberg Neuroscience Center, Department of Experimental Medical Science, Lund, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Kajsa Brolin
  • For correspondence: kajsa.brolin@med.lu.se manuela.tan@medisin.uio.no
Sara Bandres-Ciga
2Molecular Genetics Section, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, 20892, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hampton Leonard
2Molecular Genetics Section, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, 20892, USA
3Center for Alzheimer’s and Related Dementias, National Institute on Aging, Bethesda, MD, 20892, USA
4Data Tecnica International, Glen Echo, MD, 20812, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mary B. Makarious
2Molecular Genetics Section, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, 20892, USA
4Data Tecnica International, Glen Echo, MD, 20812, USA
5Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, University College London, London, UK
6UCL Movement Disorders Centre, University College London, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mary B. Makarious
Cornelis Blauwendraat
2Molecular Genetics Section, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, 20892, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ignacio F Mata
7Lerner Research Institute, Genomic Medicine, Cleveland Clinic Foundation, Cleveland, OH, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ignacio F Mata
Jia Nee Foo
8Lee Kong Chian School of Medicine, Nanyang Technological University Singapore, Singapore
9Human Genetics, Genome Institute of Singapore, A*STAR, Singapore
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lasse Pihlstrøm
10Department of Neurology, Oslo University Hospital, Oslo, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maria Swanberg
1Lund University, Translational Neurogenetics Unit, Wallenberg Neuroscience Center, Department of Experimental Medical Science, Lund, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ziv Gan-Or
11Department of Human Genetics, McGill University, Montreal, Quebec, Canada
12Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada
13Department of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Manuela MX Tan
10Department of Neurology, Oslo University Hospital, Oslo, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: kajsa.brolin@med.lu.se manuela.tan@medisin.uio.no
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Parkinson’s disease (PD) is a complex neurodegenerative disorder in which both rare and common genetic variants contribute to disease risk. Multiple genes have been reported to be linked to monogenic PD, but these only explain a fraction of the observed familial aggregation. Rare variants in RIC3 have been suggested to be associated with PD in the Indian population. However, replication studies yielded inconsistent results. We further investigate the role of RIC3 variants in PD in European cohorts using individual-level genotyping data from 14,671 PD patients and 17,667 controls, as well as whole-genome sequencing data from 1,615 patients and 961 controls. We also investigated RIC3 using summary statistics from a Latin American cohort of 1,481 individuals, and from a cohort of 31,575 individuals of East Asian ancestry. We did not identify any association between RIC3 and PD in any of the cohorts. However, more studies of rare variants in non-European ancestry populations, in particular South Asian populations, are necessary to further evaluate the world-wide role of RIC3 in PD etiology.

Competing Interest Statement

The authors have declared no competing interest.

Clinical Protocols

https://github.com/ipdgc/IPDGC-Trainees/blob/master/RIC3.ipynb

Funding Statement

This work was supported in part by the Norwegian South-East Regional Health Authority (Helse Sor-Ost RHF) (supporting MMXT and LP) and in part by the Swedish Research Council (VR) and Ake Wiberg's foundation (supporting KB and MS). We would also like to thank the Accelerating Medicines Partnership - Parkinson's disease (AMP-PD). Data used in preparation of this article were obtained from the AMP-PD Knowledge Platform in which the clinical data and biosamples were obtained from the Fox Investigation for New Discovery of Biomarkers (BioFIND), the Harvard Biomarker Study (HBS), the Parkinson's Progression Markers Initiative (PPMI), and the Parkinson's Disease Biomarkers Program (PDBP). The investigators for each cohort have not participated in reviewing the data analysis or content of the manuscript.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Data used in preparation of this article were obtained from the publicly available, but controlled access, data from the Accelerating Medicines Partnership - Parkinson's disease (AMP-PD) Knowledge Platform in which the clinical data and biosamples were obtained from the Fox Investigation for New Discovery of Biomarkers (BioFIND), the Harvard Biomarker Study (HBS), the Parkinson's Progression Markers Initiative (PPMI), and the Parkinson's Disease Biomarkers Program (PDBP). AMP-PD has approved the study. As the analyses in this manuscript utitlize secondary analyses of suitably anonymized datasets, they do not require ethics committee review. The respective ethical committees for medical research approved involvement in genetic studies and all participants gave written informed consent in the original publications for the datasets used. The details of these studies can be obtained from the AMP PD website (https://amp-pd.org) and each study website

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Data used in preparation of this article were obtained from the AMP-PD Knowledge Platform in which the clinical data and biosamples were obtained from the Fox Investigation for New Discovery of Biomarkers (BioFIND), the Harvard Biomarker Study (HBS), the Parkinson's Progression Markers Initiative (PPMI), and the Parkinson's Disease Biomarkers Program (PDBP). The investigators for each cohort have not participated in reviewing the data analysis or content of the manuscript. All code for these analyses is available at: https://github.com/ipdgc/IPDGC-Trainees/blob/master/RIC3.ipynb.

https://www.amp-pd.org

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted June 28, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
RIC3 variants are not associated with Parkinson’s Disease in large European, Latin American, or East Asian cohorts
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
RIC3 variants are not associated with Parkinson’s Disease in large European, Latin American, or East Asian cohorts
Kajsa Brolin, Sara Bandres-Ciga, Hampton Leonard, Mary B. Makarious, Cornelis Blauwendraat, Ignacio F Mata, Jia Nee Foo, Lasse Pihlstrøm, Maria Swanberg, Ziv Gan-Or, Manuela MX Tan, International Parkinson’s Disease Genomics Consortium (IPDGC)
medRxiv 2021.06.22.21259012; doi: https://doi.org/10.1101/2021.06.22.21259012
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
RIC3 variants are not associated with Parkinson’s Disease in large European, Latin American, or East Asian cohorts
Kajsa Brolin, Sara Bandres-Ciga, Hampton Leonard, Mary B. Makarious, Cornelis Blauwendraat, Ignacio F Mata, Jia Nee Foo, Lasse Pihlstrøm, Maria Swanberg, Ziv Gan-Or, Manuela MX Tan, International Parkinson’s Disease Genomics Consortium (IPDGC)
medRxiv 2021.06.22.21259012; doi: https://doi.org/10.1101/2021.06.22.21259012

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Genetic and Genomic Medicine
Subject Areas
All Articles
  • Addiction Medicine (216)
  • Allergy and Immunology (495)
  • Anesthesia (106)
  • Cardiovascular Medicine (1097)
  • Dentistry and Oral Medicine (196)
  • Dermatology (141)
  • Emergency Medicine (274)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (502)
  • Epidemiology (9773)
  • Forensic Medicine (5)
  • Gastroenterology (481)
  • Genetic and Genomic Medicine (2313)
  • Geriatric Medicine (223)
  • Health Economics (462)
  • Health Informatics (1562)
  • Health Policy (736)
  • Health Systems and Quality Improvement (604)
  • Hematology (238)
  • HIV/AIDS (504)
  • Infectious Diseases (except HIV/AIDS) (11650)
  • Intensive Care and Critical Care Medicine (617)
  • Medical Education (238)
  • Medical Ethics (67)
  • Nephrology (257)
  • Neurology (2144)
  • Nursing (134)
  • Nutrition (337)
  • Obstetrics and Gynecology (427)
  • Occupational and Environmental Health (518)
  • Oncology (1180)
  • Ophthalmology (364)
  • Orthopedics (128)
  • Otolaryngology (220)
  • Pain Medicine (147)
  • Palliative Medicine (50)
  • Pathology (311)
  • Pediatrics (695)
  • Pharmacology and Therapeutics (300)
  • Primary Care Research (267)
  • Psychiatry and Clinical Psychology (2182)
  • Public and Global Health (4663)
  • Radiology and Imaging (778)
  • Rehabilitation Medicine and Physical Therapy (457)
  • Respiratory Medicine (624)
  • Rheumatology (274)
  • Sexual and Reproductive Health (226)
  • Sports Medicine (210)
  • Surgery (252)
  • Toxicology (43)
  • Transplantation (120)
  • Urology (94)